Wang Y, Tadimalla S, Holloway L, Thiruthaneeswaran N, Haworth A
MAGMA. 2025; .
PMID: 39985650
DOI: 10.1007/s10334-025-01231-9.
Subashi E, LoCastro E, Burleson S, Apte A, Zelefsky M, Tyagi N
Phys Imaging Radiat Oncol. 2024; 32():100678.
PMID: 39717186
PMC: 11665667.
DOI: 10.1016/j.phro.2024.100678.
Fan X, Chatterjee A, Medved M, Antic T, Oto A, Karczmar G
J Appl Clin Med Phys. 2024; 26(1):e14544.
PMID: 39568316
PMC: 11713853.
DOI: 10.1002/acm2.14544.
Kim S, Kang J, Park Y, Kim Y, Lim B, Park J
Sci Rep. 2024; 14(1):9902.
PMID: 38688960
PMC: 11061152.
DOI: 10.1038/s41598-024-60413-y.
Fennessy F, Maier S
Eur J Radiol. 2023; 167:111066.
PMID: 37651828
PMC: 10623580.
DOI: 10.1016/j.ejrad.2023.111066.
Magnetic Resonance Image Compilation Was Used in Conjunction with Prostate PI-RADS v2.1 Score Has Diagnostic Relevance for Benign and Malignant Prostate Lesions.
Xu W, Cao H, Du F, He L, Jiang F, Hu C
Comput Math Methods Med. 2022; 2022:3613540.
PMID: 36072774
PMC: 9444436.
DOI: 10.1155/2022/3613540.
Emerging MR methods for improved diagnosis of prostate cancer by multiparametric MRI.
Dwivedi D, Jagannathan N
MAGMA. 2022; 35(4):587-608.
PMID: 35867236
DOI: 10.1007/s10334-022-01031-5.
T2 mapping for the characterization of prostate lesions.
Hepp T, Kalmbach L, Kolb M, Martirosian P, Hilbert T, Thaiss W
World J Urol. 2022; 40(6):1455-1461.
PMID: 35357510
PMC: 9166840.
DOI: 10.1007/s00345-022-03991-8.
Three-dimensional nuclear magnetic resonance spectroscopy: a complementary tool to multiparametric magnetic resonance imaging in the identification of aggressive prostate cancer at 3.0T.
Deal M, Bardet F, Walker P, Vega M, Cochet A, Cormier L
Quant Imaging Med Surg. 2021; 11(8):3749-3766.
PMID: 34341747
PMC: 8245930.
DOI: 10.21037/qims-21-331.
Diffusion tensor-based fiber tracking of the male urethral sphincter complex in patients undergoing radical prostatectomy: a feasibility study.
Verde A, Santinha J, Carrasquinha E, Loucao N, Gaivao A, Fonseca J
Insights Imaging. 2020; 11(1):126.
PMID: 33245443
PMC: 7695769.
DOI: 10.1186/s13244-020-00927-x.
Clinical utility of combined T2-weighted imaging and T2-mapping in the detection of prostate cancer: a multi-observer study.
Lee C, Taupitz M, Asbach P, Lenk J, Haas M
Quant Imaging Med Surg. 2020; 10(9):1811-1822.
PMID: 32879859
PMC: 7417765.
DOI: 10.21037/qims-20-222.
Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.
Panda A, OConnor G, Lo W, Jiang Y, Margevicius S, Schluchter M
Invest Radiol. 2019; 54(8):485-493.
PMID: 30985480
PMC: 6602844.
DOI: 10.1097/RLI.0000000000000569.
The emerging role of imaging in prostate cancer secondary screening: multiparametric magnetic resonance imaging and the incipient incorporation of molecular imaging.
Azadi J, Nguyen M, Leroy A, Macura K, Gorin M, Rowe S
Br J Radiol. 2018; 91(1090):20170960.
PMID: 30048145
PMC: 6350472.
DOI: 10.1259/bjr.20170960.
Stimulated echo based mapping (STEM) of T , T , and apparent diffusion coefficient: validation and protocol optimization.
Zhang Y, Wells S, Hernando D
Magn Reson Med. 2018; 81(1):167-181.
PMID: 30024051
PMC: 6258304.
DOI: 10.1002/mrm.27358.
Performance of T2 Maps in the Detection of Prostate Cancer.
Chatterjee A, Devaraj A, Mathew M, Szasz T, Antic T, Karczmar G
Acad Radiol. 2018; 26(1):15-21.
PMID: 29731420
PMC: 6215527.
DOI: 10.1016/j.acra.2018.04.005.
A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
Gaur S, Harmon S, Gupta R, Margolis D, Lay N, Mehralivand S
Acad Radiol. 2018; 26(1):5-14.
PMID: 29705281
PMC: 6202287.
DOI: 10.1016/j.acra.2018.03.024.
Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia.
Zhang X, Yu X, Du Z, Miao X, Lu J, Zhou Q
Oncol Lett. 2018; 15(5):6541-6546.
PMID: 29616121
PMC: 5876421.
DOI: 10.3892/ol.2018.8131.
Development of a measure for evaluating lesion-wise performance of CAD algorithms in the context of mpMRI detection of prostate cancer.
Leng E, Spilseth B, Zhang L, Jin J, Koopmeiners J, Metzger G
Med Phys. 2018; 45(5):2076-2088.
PMID: 29542824
PMC: 6734092.
DOI: 10.1002/mp.12861.
Multi-parametric MRI imaging of the prostate-implications for focal therapy.
Wysock J, Lepor H
Transl Androl Urol. 2017; 6(3):453-463.
PMID: 28725587
PMC: 5503978.
DOI: 10.21037/tau.2017.04.29.
Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T mapping across multiple systems.
van Houdt P, Agarwal H, van Buuren L, Heijmink S, Haack S, van der Poel H
Magn Reson Med. 2017; 79(3):1586-1594.
PMID: 28671331
PMC: 5752635.
DOI: 10.1002/mrm.26816.